Development of spontaneous neuropathy in NF-κBp50-deficient mice by calcineurin-signal involving impaired NF-κB activation

Molecular Vision

Volumn 17, Issue , 2011, Pages 2157-2170

  Nakamura Yanagidaira, Tomoko ^a   Takahashi, Yasuko ^a   Sano, Kenji ^b   Murata, Toshinori ^a   Hayashi, Takuma ^a  

^a SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOMERIZINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID; NUCLEAR FACTOR KAPPA B P50; PROTEIN BAX; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; HISTOPATHOLOGY; LOW TENSION GLAUCOMA; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CALCINEURIN; GENES, REPORTER; HUMANS; INTRAVITREAL INJECTIONS; LUCIFERASES; MEMANTINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; NF-KAPPA B P50 SUBUNIT; OPTIC NERVE; OPTIC NERVE DISEASES; PIPERAZINES; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; TACROLIMUS;

EID: 80053025920     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res 1999; 18:39-57. [PMID: 9920498]
2. Tezel G, Wax MB. Glaucoma. Chem Immunol Allergy 2007; 92:221-7. [PMID: 17264498]
3. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 1996; 37:1618-24. [PMID: 8675405]
4. Votruba M. Molecular genetic basis of primary inherited optic neuropathies. Eye (Lond) 2004; 18:1126-32. [PMID: 15534598]
5. Baeuerle PA, Baltimore D. IkappaB: aspecificinhibitor of theNF-kappa Btranscription factor. Science 1988; 242:540-6. [PMID: 3140380]
6. Mattson MP, Meffert MK. Roles of NF-kappa B in nerve cell survival, plasticity, and disease. Cell Death Differ 2006; 13:852-60. [PMID: 16397579]
7. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 1995; 80:321-30. [PMID: 7834752]
8. Hoffmann A, Lung TH, Baltimore D. Genetic analysis of NFkappa B/Rel transcription factoers defines functional specificities. EMBO J 2003; 22:5530-9. [PMID: 14532125]
9. Fan W, Cooper NG. Glutamate-induced NFkappaBactivation in the retina. Invest Ophthalmol Vis Sci 2009; 50:917-25. [PMID: 18836176]
10. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection byaspirin and sodium salicylate through blockade of NFkappaB activation. Science 1996; 274:1383-5. [PMID: 8910280]
11. Nakai M, Qin ZH, Chen JF, Wang Y, Chase TN. Kainic acidinduced apoptosis in rat striatum is associated with nuclear factor-kappa B activation. J Neurochem 2000; 74:647-58. [PMID: 10646516]
12. Chen YG, Zhang C, Chiang SK, Wu T, Tso MO. Increased nuclear factor-kappa B p65 immunoreactivity following retinal ischemia and reperfusion injury in mice. J Neurosci Res 2003; 72:125-31. [PMID: 12645086]
13. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1:623-34. [PMID: 2908446]
14. Lam TT, Abler AS, Kwong JM, Tso MO. N-Methyl-DAspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci 1999; 40:2391-7. [PMID: 10476807]
15. Lipton SA. Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv Ophthalmol 2003; 48:S38-46. [PMID: 12852433]
16. Toriu N, Akaike A, Yasuyoshi H, Zhang S, Kashii S, Honda Y, Shimazawa M, Hara N. Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res 2000; 70:475-84. [PMID: 10865996]
17. Seitz DP. Pasha Mk, Singh B, Chu A, Sharma RK. Localization and characterization of calcineurin in bovine eye. Invest Ophthalmol Vis Sci 2002; 43:15-21. [PMID: 11773007]
18. Nakazawa A, Usuda N, Matsui T, Hanai T, Matsushita S, Arai H, Sasaki H, Higuchi SJ. Localization of calcineurin in the mature and developing retina. J Histochem Cytochem 2001; 49:187-95. [PMID: 11156687]
19. Wu HY, Tomizawa K, Oda Y, Wei F, Lu YF, Matsushita M, Li ST, Moriwaki A, Matsui H. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem 2004; 279:4929-40. [PMID: 14627704]
20. Sharkey J, Butcher SP. Immunophilins mediatethe neuroprotectiveeffects of FK506 in focal cerebral ischaemia. Nature 1994; 371:336-9. [PMID: 7522303]
21. Saxena K, Patro N, Patro I. FK506 protects following peripheral nerve injury via immunosuppression. Cell Mol Neurobiol 2007; 27:1049-57. [PMID: 18080746]
22. Freeman EE, Grosskreutz CL. The effects of FK506 on retinal ganglion cells after optic nerve crush. Invest Ophthalmol Vis Sci 2000; 41:1111-5. [PMID: 10752948]
23. Huang W, Fileta JB, Dobberfuhl A, Filippopolous T, Guo Y, Kwon G, Grosskreutz CL. Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc Natl Acad Sci USA 2005; 102:12242-7. [PMID: 16103353]
24. Kikuchi M, Kashii S, Mandai M, Yasuyoshi H, Honda Y, Kaneda K, Akaike A. Protective effects of FK506 against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci 1998; 39:1227-32. [PMID: 9620083]
25. Takahashi Y, Katai N, Murata T, Taniguchi SI, Hayashi T. Development of spontaneous optic neuropathy in NFkappaBetap50-deficient mice; requirement for NF-kappa Beta p50 in ganglion cell survival. Neuropathol Appl Neurobiol 2007; 33:692-705. [PMID: 17931357]
26. Hayashi T, Faustman D. Essential role of human leukocyte antigen-encoded subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis. J Biol Chem 2000; 275:5238-47. [PMID: 10671572]
27. Iriyama T, Kamei Y, Kozuma S, Taketani Y. Bax-inhibiting peptide protects glutamate-induced cerebellar granule cell death by blocking Bax translocation. Neurosci Lett 2009; 451:11-5. [PMID: 19110033]
28. Huang W, Fileta JB, Dobberfuhl A, Filippopolous T, Guo Y, Kwon G, Grosskreutz CL. Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc Natl Acad Sci USA 2005; 102:12242-7. [PMID: 16103353]
29. Youle RJ, Strasser A. The BCL-2-protein family: opposingactivities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9:47-59. [PMID: 18097445]
30. Guan H, Hou S, Ricciardi RP. DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. J Biol Chem 2005; 280:9957-62. [PMID: 15642694]
31. Perkins ND, Schmid RM, Duckett CS, Leung K, Rice NR, Nabel GJ. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci USA 1992; 89:1529-33. [PMID: 1542644]
32. Bonomi L, Marchini G, Marraffa M, Bernardi P, De Franco I, Perfetti S, Varotto A, Tenna V. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology 1998; 105:209-15. [PMID: 9479277]
33. Osborne NN, Lascoratos G, Bron AJ, Chidlow G, Wood JP. Ahypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br J Ophthalmol 2006; 90:237-41. [PMID: 16424541]
34. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol 2007; 125:30-7. [PMID: 17210849]
35. Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, Saeki T, Aihara M, Yoshida H, Mitani A, Tanaka K. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 2007; 117:1763-70. [PMID: 17607354]
36. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci USA 1997; 94:7531-6. [PMID: 9207126]
37. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kappaBis activated in primaryneurons byamyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 1997; 94:2642-7. [PMID: 9122249]
38. Lipton SA. Janus faces of NF-kappa B: neurodestruction versus neuroprotection. Nat Med 1997; 3:20-2. [PMID: 8986730]
39. O'Neill LA, Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997; 20:252-8. [PMID: 9185306]
40. Hara H, Morita T, Sukamoto T, Cutrer FM. Lomerizine (KB-2796), a new antimigraine drug. CNS Drug Reviews 1995 1:204-26.
41. Jefferson KK. Smith JrMF, Bobak DA. Roles of intracellular calcium and NF-kappa B in the Clostridium difficile toxin Ainduced up-regulation and secretion of IL-8 from human monocytes. J Immunol 1999; 163:5183-91. [PMID: 10553038]
42. Pahl HL, Baeuerle PA. Activation of NF-kappa B by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers. FEBS Lett 1996; 392:129-36. [PMID: 8772190]
43. Lilienbaum A, Israel A. From calcium to NF-kappa B signaling pathways in neurons. Mol Cell Biol 2003; 23:2680-98. [PMID: 12665571]
44. Wessman M, Kallela M, Kaunisto MA, Marttila P, Sobel E, Hartiala J, Oswell G, Leal SM, Papp JC, Hamalainen E, Broas P, Joslyn G, Hovatta I, Hiekkalinna T. kaprio J, Cantor RM, Zwart JA, Ilmavirta, M, havanka H, Farkkila M, Peltonen L, Palotie A. Asusceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet 2002; 70:652-62. [PMID: 11836652]